A Study Using Recombinant Human Luteinizing Hormone (r-hLH, Luveris®) in the Treatment of Chinese Women With Hypogonadotropic Hypogonadism
Clinical trial NCT01084265 · COMPLETED
Trial details
- NCT number
- NCT01084265
- Sponsor
- Merck KGaA, Darmstadt, Germany
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2004-02-01
- Primary completion
- 2005-12-01
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.